Lineage, Inc. Common Stock (LINE)vsStar Holdings (STHO)
LINE
Lineage, Inc. Common Stock
$42.63
-1.32%
REAL ESTATE · Cap: $11.14B
STHO
Star Holdings
$8.87
0.00%
REAL ESTATE · Cap: $108.86M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 4207% more annual revenue ($5.36B vs $124.46M). LINE leads profitability with a -2.7% profit margin vs -53.7%. STHO earns a higher WallStSmart Score of 45/100 (D).
LINE
Avoid34
out of 100
Grade: F
STHO
Hold45
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
-29.2%
Fair Value
$6.20
Current Price
$8.87
$2.67 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Revenue surging 43.2% year-over-year
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Smaller company, higher risk/reward
ROE of -28.0% — below average capital efficiency
Earnings declined 98.0%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : STHO
The strongest argument for STHO centers on Price/Book, Revenue Growth. Revenue growth of 43.2% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : STHO
The primary concerns for STHO are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while STHO is a hypergrowth play — different risk/reward profiles.
STHO is growing revenue faster at 43.2% — sustainability is the question.
STHO generates stronger free cash flow (-9M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
STHO scores higher overall (45/100 vs 34/100) and 43.2% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →Star Holdings
REAL ESTATE · REAL ESTATE SERVICES · USA
Star Holdings engages in the non-ground lease related commercial real estate businesses in the United States. The company is headquartered in New York, New York.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?